CD19 and B-cell acute lymphoblastic leukemia: Antigenic drift is an established mechanism of immunotherapy evasion, most notably in B-cell acute lymphoblastic leukemia, where CD19 loss affects 40% of patients following anti-CD19 CAR T therapy (6).